Aurobindo Pharma

  • PharmaTutor
    26 April 2019

    Job for M.Pharm, M.Sc, B.Pharm in Production, Quality Control, IPQA, QMS, Validations at Aurobindo Pharma

    Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

  • 5 April 2019
    Walk in interview in Production, Quality Control, Packing at Aurobindo Pharma

    Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

  • 3 May 2018
    Job in Production, Packing, QA, QC Department at Aurobindo Pharma | M.Pharm, B.Pharm, M.Sc can apply

    Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK, MHRA etc. with a turnover of more than $2.5 billion dollars. Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

  • 1 September 2017
    Walk in interview for M.Pharm, B.Pharm, M.Sc in QA, QC, Production at Aurobindo

    A leading pharmaceutical company having 23 plants woridwide with regulatory approvals from USFDA, UK, MHRA, etc., with a turnover of more than $2.5 billion, invites applications for the following positions for its automated and most modem Injectable Formulation Units located at Hyderabad and Jedcherta (SEZ) to meet the existing and expansion requirements.

  • Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fenofibrate Tablets, 48 mg and 145 mg. Fenofibrate Tablet is used to treat high level of cholesterol and triglyceride in the blood. Product is expected to be launched in Q1 FY16-17.

  • Hyderabad-based Aurobindo Pharma received the final approval from the US Food and Drug Administration to manufacture and market generic Aripiprazole tablets used for treatment of psychotic conditions in the American market. The approval is for the tablets in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg and 30mg.

  • Aurobindo Pharma got final approvals from the US FDA of azithromycin for injection USP, 500mg /vial and entacapone tablets. Azithromycin for injection USP, 500mg/vial is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zithromax (azithromycin for injection) 500mg/vial of Pfizer, Inc. Azithromycin for injection, USP is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions such as community-acquired pneumonia and pelvic inflammatory disease.

Subscribe to Aurobindo Pharma